Variables | n = 2666 |
---|---|
Age (years) | 74.9 ± 8.4 |
Male gender | 1647 (61.9%) |
Obesity | 766 (31.6%) |
Admission blood glucose (mg/dL) | 153 ± 45.7 |
Admission serum creatinine (mg/dL) | 1.03 ± 0.23 |
Admission aspartate aminotransferase (U/L) | 31 ± 8 |
Admission alanine aminotransferase (U/L) | 26 ± 6 |
Metformin | 1618 (60.8%) |
DPP-4i | 791 (30.2%) |
GLP1-1RA | 127 (4.8%) |
SGLT-2i | 296 (11.3%) |
Insulin | 723 (27.6%) |
Angiotensin-converting enzyme inhibitor | 724 (27.4%) |
Angiotensin II receptor blocker | 789 (29.9%) |
Statin | 1534 (58.0%) |
Antiplatelet | 643 (24.8%) |
Anticoagulant | (16.3%) |
History of smoking | 955 (35.8%) |
Hypertension | 2026 (76.2%) |
Dyslipidemia | 1730 (65.0%) |
Chronic kidney disease | 352 (13.2%) |
Atrial fibrillation | 444 (16.7%) |
Coronary artery disease | 610 (22.9%) |
Heart failure | 445 (16.7%) |
Chronic obstructive pulmonary disease | 346 (13.0%) |
Liver disease | 172 (6.5%) |
Cancer | 353 (13.3%) |
Stroke | 322 (12.1%) |
Dementia | 384 (14.4%) |
Depression | 308 (11.6%) |
Moderate-severe functional dependence | 636 (24.2%) |
Moderate-severe comorbidity | 2338 (90.7%) |
Disease severity | |
Moderate | 1891 (70.9%) |
Severe | 714 (26.8%) |
Critical | 61 (2.3%) |
Hydroxychloroquine | 2185 (82.0%) |
Chloroquine | 72 (2.7%) |
Lopinavir/ritonavir | 1195 (44.8%) |
Azithromycin | 1595 (59.8%) |
Remdesivir | 36 (1.4%) |
Interferon-β | 276 (10.4%) |
Corticosteroids | 1186 (44.5%) |
Tocilizumab | 215 (8.1%) |